Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Other financing activities: 2024

Historic Other financing activities for Zenas BioPharma (ZBIO) over the last 1 years, with Dec 2024 value amounting to $4.5 million.

  • Zenas BioPharma's Other financing activities was N/A to $4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $6.3 million for FY2024, which is N/A change from last year.
  • Zenas BioPharma's Other financing activities amounted to $4.5 million in Q4 2024, which was up 918.91% from $439,000 recorded in Q3 2024.
  • Zenas BioPharma's Other financing activities' 5-year high stood at $4.5 million during Q4 2024, with a 5-year trough of $439,000 in Q3 2024.
  • Over the past 1 years, Zenas BioPharma's median Other financing activities value was $711,000 (recorded in 2024), while the average stood at $1.6 million.